You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematopoietic Stem Cell Malignancies

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Xiamen (Icotinib, Befotertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Xiamen, Fujian, China
    Feng Ye
Sep 17, 2021

Head and Neck Squamous Cell Cancer Trial in Shanghai (Toripalimab Injection, Cetuximab Solution for infusion)

Recruiting
  • Head and Neck Squamous Cell Cancer
  • Toripalimab Injection
  • Cetuximab Solution for infusion
  • Shanghai, China
    Shanghai East Hospital
Dec 15, 2022

Influenza, Influenza-like Illness, Influenza Vaccines Trial in United States (Egg based influenza vaccines, Recombinant

Recruiting
  • Influenza
  • +2 more
  • Egg based influenza vaccines
  • +2 more
  • San Diego, California
  • +8 more
Dec 22, 2021

Squamous Cell Carcinoma of the Oropharynx Trial in Paris (Tumor Biopsy)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • Tumor Biopsy
  • Paris, France
  • +2 more
Sep 25, 2023

Marginal Zone B-cell Lymphoma Trial in Korea, Republic of (bendamustine plus rituximab)

Completed
  • Marginal Zone B-cell Lymphoma
  • bendamustine plus rituximab
  • Jeonju, Jeollabuk-do, Korea, Republic of
  • +10 more
Sep 23, 2021

Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)

Completed
  • Anemia
  • +2 more
    • Muenster, Germany
      Dept. of Anesthesiology, Intensive Care and Pain Medicine, UKM
    Sep 30, 2021

    Itch Trial in AAlborg (Capsaicin, Diphenhydramine, Morphine Chloride)

    Completed
    • Itch
    • AAlborg, Nordjylland, Denmark
      Mech-Sense, Medicinsk Gastroenterologisk ambulatorium, Medicines
    Jan 26, 2022

    Tolerance of Brigatinib in Management of Rearranged CBNPC ROS1

    Completed
    • Lung Cancer ROS Translocated
      • Créteil, France
        CHI Créteil
      Nov 19, 2021

      Development of Predictive Biomarkers

      Completed
      • Type1diabetes
      • Mixed Meal Tolerance Test
      • Milwaukee, Wisconsin
        Medical College of Wisconsin
      Nov 28, 2021

      Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)

      Recruiting
      • Indolent Systemic Mastocytosis
      • Rochester, Minnesota
      • +6 more
      Nov 29, 2021

      TEAM Conditioning in Patients With Lymphoma (TEAM)

      Completed
      • Lymphoma
        • Paris, France
          Mohamad Mohty
        May 19, 2020

        Wound Heal, Tooth Extraction Status Nos Trial in Istanbul (Hyaluronic Acid Topical Gels, Diode Laser Biostimulation)

        Enrolling by invitation
        • Wound Heal
        • Tooth Extraction Status Nos
        • Hyaluronic Acid Topical Gels
        • Diode Laser Biostimulation
        • Istanbul, Kağıthane, Turkey
          Istanbul Atlas University
        Mar 1, 2023

        Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV

        Recruiting
        • Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
        • +2 more
        • Phoenix, Arizona
        • +11 more
        Aug 6, 2022

        Williams Syndrome and Supravalvular Aortic Stenosis DNA and

        Recruiting
        • Williams Syndrome
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 23, 2023

          Ocular Inflammation and Pain After Cataract Surgery Trial in United States (APP13007, 0.05%, Matching Vehicle Placebo for

          Recruiting
          • Ocular Inflammation and Pain After Cataract Surgery
          • APP13007, 0.05%
          • Matching Vehicle Placebo for APP13007, 0.05%
          • Mesa, Arizona
          • +31 more
          Mar 15, 2022

          Atrophy of Macula GCC by OCT and Whole Brain Atrophy by MRI to

          Active, not recruiting
          • Multiple Sclerosis
          • Brain MRI
          • +2 more
          • Nîmes, France
            CHU de Nimes
          Jan 6, 2022

          Early-stage, Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Beijing (Anti-PD-1 mAb)

          Recruiting
          • Early-stage
          • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
          • Anti-PD-1 monoclonal antibody
          • Beijing, Beijing, China
            National Cancer Center/National Clinical Research Center for Can
          Dec 7, 2021

          NSCLC, EGF-R Positive NSCLC Trial in Shanghai (Furmonertinib)

          Recruiting
          • NSCLC
          • EGF-R Positive Non-Small Cell Lung Cancer
          • Shanghai, Shanghai, China
            Shanghai General Hospital
          Jan 12, 2022

          Esophageal Squamous Cell Carcinoma Trial in United States (Nivolimumab+Carboplatin/paclitaxel+Radiation)

          Terminated
          Has Results
          • Esophageal Squamous Cell Carcinoma
          • La Jolla, California
          • +4 more
          Mar 2, 2022

          NSCLC Stage IV, Brain Metastases, Immunotherapy Trial in Hangzhou (Immunotherapy, WBRT, Chemotherapy)

          Recruiting
          • NSCLC Stage IV
          • +2 more
          • Hangzhou, Zhejiang, China
            Zhejiang Cancer Hospital
          Sep 3, 2021

          Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
          • BCG combined with Tislelizumab
          • Shanghai, Shanghai, China
            Ruijin Hospital, Shanghai Jiaotong University School of Medicine
          Oct 12, 2022

          Familial Adenomatous Polyposis Trial in Amsterdam (Lithium Carbonate)

          Enrolling by invitation
          • Familial Adenomatous Polyposis
          • Lithium Carbonate
          • Amsterdam, Noord-Holland, Netherlands
            Academic Medical Centre
          Jun 22, 2022

          Type I IFN Level and Disease Activity in SLE Patients

          Not yet recruiting
          • Elevated Level of IFN Type I in SLE Patients
          • study of IFNGS expression biomarkers
          • (no location specified)
          Jun 30, 2022

          Zevalin Post-marketing Surveillance in Japan

          Completed
          • Non-Hodgkin's Lymphoma (NHL)
          • [90]Y-ibritumomab tiuxetan (Zevalin, BAY86-5128)
          • Multiple Locations, Japan
            (unnamed)
          Sep 30, 2021

          Diabetes, Type 2 Trial in Hong Kong (Dorzagliatin, )

          Completed
          • Diabetes Mellitus, Type 2
          • Hong Kong, Hong Kong
            The Chinese University of Hong Kong
          Jul 19, 2022